Citations to this article
Abstract
BACKGROUND Genomic and experimental studies suggest a role for PITX2 in atrial fibrillation (AF). To assess if this association is relevant for recurrent AF in patients, we tested whether left atrial PITX2 affects recurrent AF after AF ablation.METHODS mRNA concentrations of PITX2 and its cardiac isoform, PITX2c, were quantified in left atrial appendages (LAAs) from patients undergoing thoracoscopic AF ablation, either in whole LAA tissue (n = 83) or in LAA cardiomyocytes (n = 52), and combined with clinical parameters to predict AF recurrence. Literature suggests that BMP10 is a PITX2-repressed, atrial-specific, secreted protein. BMP10 plasma concentrations were combined with 11 cardiovascular biomarkers and clinical parameters to predict recurrent AF after catheter ablation in 359 patients.RESULTS Reduced concentrations of cardiomyocyte PITX2, but not whole LAA tissue PITX2, were associated with AF recurrence after thoracoscopic AF ablation (16% decreased recurrence per 2–(ΔΔCt) increase in PITX2). RNA sequencing, quantitative PCR, and Western blotting confirmed that BMP10 is one of the most PITX2-repressed atrial genes. Left atrial size (HR per mm increase [95% CI], 1.055 [1.028, 1.082]); nonparoxysmal AF (HR 1.672 [1.206, 2.318]), and elevated BMP10 (HR 1.339 [CI 1.159, 1.546] per quartile increase) were predictive of recurrent AF. BMP10 outperformed 11 other cardiovascular biomarkers in predicting recurrent AF.CONCLUSIONS Reduced left atrial cardiomyocyte PITX2 and elevated plasma concentrations of the PITX2-repressed, secreted atrial protein BMP10 identify patients at risk of recurrent AF after ablation.TRIAL REGISTRATION ClinicalTrials.gov NCT01091389, NL50069.018.14, Dutch National Registry of Clinical Research Projects EK494-16.FUNDING British Heart Foundation, European Union (H2020), Leducq Foundation.
Authors
Jasmeet S. Reyat, Winnie Chua, Victor R. Cardoso, Anika Witten, Peter M. Kastner, S. Nashitha Kabir, Moritz F. Sinner, Robin Wesselink, Andrew P. Holmes, Davor Pavlovic, Monika Stoll, Stefan Kääb, Georgios V. Gkoutos, Joris R. de Groot, Paulus Kirchhof, Larissa Fabritz
Citations to this article in year 2021 (8)
| Title and authors | Publication | Year |
|---|---|---|
|
Transcriptional factors in calcium mishandling and atrial fibrillation development
W Dai, S Kesaraju, CR Weber |
Pflügers Archiv - European Journal of Physiology | 2021 |
|
In Silico Assessment of Class I Antiarrhythmic Drug Effects on Pitx2-Induced Atrial Fibrillation: Insights from Populations of Electrophysiological Models of Human Atrial Cells and Tissues
J Bai, Y Zhu, A Lo, M Gao, Y Lu, J Zhao, H Zhang |
International journal of molecular sciences | 2021 |
|
The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies
NM Stege, RA de Boer, MP van den Berg, HH Silljé |
International journal of molecular sciences | 2021 |
|
Genetics of atrial fibrillation
JA Kim, MG Chelu, N Li |
Current Opinion in Cardiology | 2021 |
|
Genetics of atrial fibrillation—practical applications for clinical management: if not now, when and how?
S Kany, B Reissmann, A Metzner, P Kirchhof, D Darbar, RB Schnabel |
Cardiovascular Research | 2021 |
|
Understanding PITX2-Dependent Atrial Fibrillation Mechanisms through Computational Models
J Bai, Y Lu, Y Zhu, H Wang, D Yin, H Zhang, D Franco, J Zhao |
International journal of molecular sciences | 2021 |
|
Atrial resting membrane potential confers sodium current sensitivity to propafenone, flecainide and dronedarone
AP Holmes, P Saxena, SN Kabir, C OShea, SM Kuhlmann, S Gupta, D Fobian, C Apicella, M OReilly, F Syeda, JS Reyat, GL Smith, AJ Workman, D Pavlovic, L Fabritz, P Kirchhof |
Heart rhythm : the official journal of the Heart Rhythm Society | 2021 |
|
Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
L Staszewsky, JM Meessen, D Novelli, UH Wienhues-Thelen, M Disertori, AP Maggioni, S Masson, G Tognoni, MG Franzosi, D Lucci, R Latini |
BMC Cardiovascular Disorders | 2021 |
